{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:49:19Z","timestamp":1791254959325,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":594,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002089","name":"Fight for Sight","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011856","name":"Mauritius Research Council","doi-asserted-by":"publisher","award":["G10002073"],"award-info":[{"award-number":["G10002073"]}],"id":[{"id":"10.13039\/501100011856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011856","name":"Mauritius Research Council","doi-asserted-by":"publisher","award":["GR0600920"],"award-info":[{"award-number":["GR0600920"]}],"id":[{"id":"10.13039\/501100011856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["079736"],"award-info":[{"award-number":["079736"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS04\/09"],"award-info":[{"award-number":["FS04\/09"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS06\/003"],"award-info":[{"award-number":["FS06\/003"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/11\/20\/28792"],"award-info":[{"award-number":["PG\/11\/20\/28792"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG08\/022\/21636"],"award-info":[{"award-number":["PG08\/022\/21636"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C11392\/A10484"],"award-info":[{"award-number":["C11392\/A10484"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["CF11392\/A8451"],"award-info":[{"award-number":["CF11392\/A8451"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY03040"],"award-info":[{"award-number":["EY03040"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000391","name":"Association for International Cancer Research","doi-asserted-by":"publisher","award":["07-0605"],"award-info":[{"award-number":["07-0605"]}],"id":[{"id":"10.13039\/501100000391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000997","name":"Arnold and Mabel Beckman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001318","name":"University of the West of England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ccr.2011.10.016","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T14:21:47Z","timestamp":1323699707000},"page":"768-780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":238,"title":["WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing"],"prefix":"10.1016","volume":"20","author":[{"given":"Elianna\u00a0M.","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Oltean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa\u00a0V.R.","family":"Gammons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hamdollah-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin\u00a0I.","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Kim","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma\u00a0S.","family":"Rennel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty\u00a0E.","family":"Symonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawid\u00a0G.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Royer-Pokora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moin\u00a0A.","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie\u00a0A.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven\u00a0J.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David\u00a0R.","family":"Hinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David\u00a0O.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael\u00a0R.","family":"Ladomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2011.10.016_bib1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1095\/biolreprod.109.078097","article-title":"Neutralization of vascular endothelial growth factor antiangiogenic isoforms is more effective than treatment with proangiogenic isoforms in stimulating vascular development and follicle progression in the perinatal rat ovary","volume":"81","author":"Artac","year":"2009","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ccr.2011.10.016_bib2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood-2011-01-328773","article-title":"Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output","volume":"118","author":"Ballmer-Hofer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2011.10.016_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1530\/REP-09-0456","article-title":"Neutralization of vascular endothelial growth factor antiangiogenic isoforms or administration of proangiogenic isoforms stimulates vascular development in the rat testis","volume":"140","author":"Baltes-Breitwisch","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.ccr.2011.10.016_bib4","first-page":"4123","article-title":"VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma","volume":"62","author":"Bates","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2011.10.016_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3835(01)00666-8","article-title":"Increased serum VEGF in 13 children with Wilms' tumour falls after surgery but rising levels predict poor prognosis","volume":"173","author":"Blann","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ccr.2011.10.016_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molcel.2008.08.008","article-title":"RBM5\/Luca-15\/H37 regulates Fas alternative splice site pairing after exon definition","volume":"32","author":"Bonnal","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccr.2011.10.016_bib7","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1101\/gad.1402306","article-title":"The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron","volume":"20","author":"Bor","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2011.10.016_bib8","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00018-006-6254-9","article-title":"A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2","volume":"63","author":"C\u00e9be Suarez","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ccr.2011.10.016_bib9","first-page":"1747s","article-title":"Multiple roles for the Wilms' tumor suppressor, WT1","volume":"59","author":"Davies","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2011.10.016_bib10","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1101\/gad.12.20.3217","article-title":"WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes","volume":"12","author":"Davies","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2011.10.016_bib11","first-page":"729","article-title":"[Association of an anatomo-pathological syndrome of male pseudohermaphroditism, Wilms' tumor, parenchymatous nephropathy and XX\/XY mosaicism]","volume":"24","author":"Denys","year":"1967","journal-title":"Arch. Fr. Pediatr."},{"key":"10.1016\/j.ccr.2011.10.016_bib12","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/ijc.23619","article-title":"p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis","volume":"123","author":"D\u00edaz","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ccr.2011.10.016_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0022-3476(70)80409-7","article-title":"A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease","volume":"76","author":"Drash","year":"1970","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.ccr.2011.10.016_bib14","doi-asserted-by":"crossref","first-page":"11329","DOI":"10.1073\/pnas.0604616103","article-title":"Utilization of host SR protein kinases and RNA-splicing machinery during viral replication","volume":"103","author":"Fukuhara","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2011.10.016_bib15","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1128\/MCB.24.18.7987-7997.2004","article-title":"Regulation of human p53\u00a0activity and cell localization by alternative splicing","volume":"24","author":"Ghosh","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ccr.2011.10.016_bib16","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1093\/hmg\/ddp317","article-title":"Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways","volume":"18","author":"Gon\u00e7alves","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ccr.2011.10.016_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3727\/000000006783991953","article-title":"Vascular endothelial growth factor (VEGF) is suppressed in WT1-transfected LNCaP cells","volume":"13","author":"Graham","year":"2006","journal-title":"Gene Expr."},{"key":"10.1016\/j.ccr.2011.10.016_bib18","doi-asserted-by":"crossref","first-page":"9618","DOI":"10.1073\/pnas.88.21.9618","article-title":"Alternative splicing and genomic structure of the Wilms tumor gene WT1","volume":"88","author":"Haber","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2011.10.016_bib19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nrc2505","article-title":"VEGF-A splicing: the key to anti-angiogenic therapeutics?","volume":"8","author":"Harper","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2011.10.016_bib20","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1158\/0008-5472.CAN-06-2969","article-title":"Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas","volume":"67","author":"Hayes","year":"2007","journal-title":"Cancer Res."},{"issue":"Spec No 2","key":"10.1016\/j.ccr.2011.10.016_bib21","doi-asserted-by":"crossref","first-page":"R196","DOI":"10.1093\/hmg\/ddl196","article-title":"The many facets of the Wilms' tumour gene, WT1","volume":"15","author":"Hohenstein","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ccr.2011.10.016_bib22","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1210\/mend-5-12-1806","article-title":"The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA","volume":"5","author":"Houck","year":"1991","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ccr.2011.10.016_bib23","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1167\/iovs.09-4360","article-title":"Recombinant human VEGF165b inhibits experimental choroidal neovascularization","volume":"51","author":"Hua","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ccr.2011.10.016_bib24","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2011.10.016_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nsmb1209","article-title":"The gene encoding the splicing factor SF2\/ASF is a proto-oncogene","volume":"14","author":"Karni","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ccr.2011.10.016_bib26","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1158\/0008-5472.CAN-07-6577","article-title":"Vascular endothelial growth factor (VEGF)-A165b is a weak in\u00a0vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity","volume":"68","author":"Kawamura","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2011.10.016_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.11721","article-title":"WT1 is a tumor-associated antigen in colon cancer that can be recognized by in\u00a0vitro stimulated cytotoxic T\u00a0cells","volume":"109","author":"Koesters","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ccr.2011.10.016_bib28","first-page":"626","article-title":"VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice","volume":"12","author":"Konopatskaya","year":"2006","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ccr.2011.10.016_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/pbc.21088","article-title":"SRPK1: a cisplatin sensitive protein expressed in retinoblastoma","volume":"50","author":"Krishnakumar","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ccr.2011.10.016_bib30","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ccr.2011.10.016_bib31","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1038\/onc.2010.281","article-title":"The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in\u00a0vivo","volume":"29","author":"Merdzhanova","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2011.10.016_bib32","first-page":"55","article-title":"The post-transcriptional roles of WT1, a multifunctional zinc-finger protein","volume":"1785","author":"Morrison","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ccr.2011.10.016_bib33","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1097\/01.ASN.0000022420.48110.4B","article-title":"A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development","volume":"13","author":"Natoli","year":"2002","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ccr.2011.10.016_bib34","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1242\/jcs.016410","article-title":"Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors","volume":"121","author":"Nowak","year":"2008","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ccr.2011.10.016_bib35","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1074\/jbc.M109.074930","article-title":"Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis","volume":"285","author":"Nowak","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccr.2011.10.016_bib36","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1007\/s00125-005-1951-8","article-title":"Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor","volume":"48","author":"Perrin","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.ccr.2011.10.016_bib37","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1096\/fj.07-9718com","article-title":"Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b","volume":"22","author":"Qiu","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ccr.2011.10.016_bib38","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1681\/ASN.2009060617","article-title":"Overexpression of VEGF165b in podocytes reduces glomerular permeability","volume":"21","author":"Qiu","year":"2010","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ccr.2011.10.016_bib39","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/sj.bjc.6604309","article-title":"The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice","volume":"98","author":"Rennel","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccr.2011.10.016_bib40","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bjc.6605249","article-title":"VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in\u00a0vivo","volume":"101","author":"Rennel","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccr.2011.10.016_bib41","doi-asserted-by":"crossref","first-page":"15042","DOI":"10.1073\/pnas.0507827102","article-title":"Reversible phosphorylation differentially affects nuclear and cytoplasmic functions of splicing factor 2\/alternative splicing factor","volume":"102","author":"Sanford","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2011.10.016_bib42","doi-asserted-by":"crossref","first-page":"e3369","DOI":"10.1371\/journal.pone.0003369","article-title":"Identification of nuclear and cytoplasmic mRNA targets for the shuttling protein SF2\/ASF","volume":"3","author":"Sanford","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ccr.2011.10.016_bib43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1681\/ASN.2006020124","article-title":"Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome","volume":"18","author":"Schumacher","year":"2007","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ccr.2011.10.016_bib44","first-page":"2274","article-title":"Angiogenesis and angiogenic growth factors in Wilms tumor","volume":"165","author":"Sk\u00f6ldenberg","year":"2001","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.ccr.2011.10.016_bib45","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/sj.bjc.6604308","article-title":"VEGF165b, an\u00a0antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment\u00a0in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy","volume":"98","author":"Varey","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccr.2011.10.016_bib46","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/pmic.200600666","article-title":"A proteomic investigation of glomerular podocytes from a Denys-Drash syndrome patient with a mutation in the Wilms tumour suppressor gene WT1","volume":"7","author":"Viney","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.ccr.2011.10.016_bib47","doi-asserted-by":"crossref","first-page":"7822","DOI":"10.1158\/0008-5472.CAN-04-0934","article-title":"VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in\u00a0vivo effect on angiogenesis and endogenous protein expression","volume":"64","author":"Woolard","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2011.10.016_bib48","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/10739680902997333","article-title":"Molecular diversity of VEGF-A as a regulator of its biological activity","volume":"16","author":"Woolard","year":"2009","journal-title":"Microcirculation"},{"key":"10.1016\/j.ccr.2011.10.016_bib49","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1053\/j.gastro.2008.02.015","article-title":"Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma","volume":"134","author":"Yea","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccr.2011.10.016_bib50","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1101\/gad.1752109","article-title":"Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones","volume":"23","author":"Zhong","year":"2009","journal-title":"Genes Dev."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610811003990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610811003990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:55:32Z","timestamp":1761522932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610811003990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1535610811003990"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2011.10.016","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2011.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}